InvestorsHub Logo
Followers 19
Posts 334
Boards Moderated 0
Alias Born 07/25/2016

Re: ahab333 post# 39269

Tuesday, 05/23/2017 11:44:44 PM

Tuesday, May 23, 2017 11:44:44 PM

Post# of 48316
Thanks, Ahab, will do.

While digging deeper into the company's patent applications and connections with one particular institution, I am convinced that they are pursuing in-situ production of antibodies, including checkpoint inhibitors, through encoded polycistronic vectors. Oncosec has the capacity to be a major disruptor.

Imagine your cells as a factory that can produce any encoded antibody when the genetic material is adequately transfected...
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ONCSQ News